RGRachel B. Ger

Rachel B. Ger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rachel B. Ger has a total of 151 co-authors. Here are the top co-authors by number of shared publications:

  • Heng Li

    Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    12 shared publications
  • Laurence Edward Court

    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX

    11 shared publications
  • Clifton David Fuller

    Department of Radiation Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA

    9 shared publications
  • Rebecca M. Howell

    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    9 shared publications
  • R. Jason Stafford

    MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences, Houston, Texas, United States of America

    8 shared publications
  • Dennis Mackin

    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

    7 shared publications

Latest Publications

  • Open Access

    Optimizing QACT Frequency in Proton Therapy: Analysis of Standard Guidelines Across Treatment Sites

    by Rachel B. Ger, Todd R. McNutt, Curtiland Deville, Aditya N. Halthore, Heng Li


  • Open Access

    Dosimetric Advantage of Scanning Beam Proton Therapy in Gynecologic Patients Receiving Adjuvant Radiotherapy

    by Rachel B. Ger, Jarrod M. Lentz, Joshua S. Niedzielski, Sujay A. Vora, Martin Bues, Danairis Hernandez Morales, Justin D. Anderson, Christopher J. Kutyreff, Christie A. Schulz, Pedro R. Lara, et al.

    Background/Objectives: Adjuvant radiation for gynecologic malignancies often exposes organs at risk (OARs), such as the bone marrow, bowel, rectum, and bladder, to radiation, leading to toxicities that impact treatment tolerance and patient quality of life. Scanning proton beam therapy, particularly with Individual Field Simultaneous Optimization (IFSO), may offer dosimetric and biological advantages over volumetric modulated arc therapy (VMAT). This study evaluates the clinical impact of IFSO-based proton planning in post-operative gynecologic cancer patients. Materials and Methods: Fourteen patients receiving adjuvant proton therapy to 45 Gy in 25 fractions were retrospectively analyzed. Comparison VMAT plans were generated on the same datasets. Dose–volume metrics for key OARs and normal tissue complication probabilities (NTCPs) were compared using paired statistical tests. Robustness evaluations accounted for setup and range uncertainties. Results: Proton plans significantly reduced dose to bone marrow (V10Gy: 58% vs. 86%, p < 0.00001; V20Gy: 47% vs. 58%, p < 0.00001), small bowel (V20Gy: 21% vs. 56%, p < 0.00001), and femoral heads (left femoral head mean: 11Gy vs. 13Gy, p = 0.032; right femoral head mean: 11Gy vs. 13Gy, p = 0.022). NTCP modeling predicted significantly lower rates of bowel urgency (9.4% vs. 3.3%, p < 0.001) and hematologic toxicity (10.2% vs. 4.9%, p < 0.001) with proton therapy. Plans remained robust across uncertainty scenarios. Conclusions: IFSO-based scanning proton therapy provides clinically meaningful sparing of bone marrow and bowel, with the potential to reduce hematologic and gastrointestinal toxicities. These findings support its use in patients receiving adjuvant pelvic radiotherapy, particularly those undergoing extended field treatment or chemotherapy.


  • Open Access

    Optimizing QACT Frequency and Setup Uncertainty in Cranial Proton Therapy for Normal Tissue Sparing

    by Rachel B. Ger, Anh Tran, Victoria J. Croog, Lawrence R. Kleinberg, Carmen Kut, Brandi R. Page, Kristin J. Redmond, Heng Li


  • Open Access

    Clinical Introduction of Stem Cell Sparing Radiotherapy to Reduce the Risk of Xerostomia in Patients with Head and Neck Cancer

    by Maria I. van Rijn-Dekker, Arjen van der Schaaf, Sanne W. Nienhuis, Antoinette S. Arents-Huls, Rachel B. Ger, Olga Hamming-Vrieze, Frank J. P. Hoebers, Mischa de Ridder, Sabrina Vigorito, Ellen M. Zwijnenburg, et al.

    Background/Objectives: Studies have shown that dose to the parotid gland stem cell rich (SCR) regions should be reduced to lower the risk of xerostomia after radiotherapy (RT). This study aimed to assess whether stem cell sparing (SCS)-RT can be adopted in routine clinical practice. Methods: Multiple planning studies were performed to compare SCS-RT with standard (ST)-RT using 30 head and neck cancer patients. Shifts in mean dose to the SCR regions (Dmean,SCR) and other organs at risk and their estimated impact on normal tissue complication probability (NTCP) for side-effects were compared using Wilcoxon signed-rank test. A multicenter study was performed (eight institutions, three patients) to test the generalizability of SCS-RT using the Friedman test. Results: Using photons, Dmean,SCR was reduced with median 4.1/3.5 Gy for ipsilateral/contralateral (p < 0.001). The largest reductions were when the SCR regions overlapped less with target volumes. Subsequently, NTCPs for xerostomia decreased (p < 0.001). Using protons, Dmean,SCR was also reduced (2.2/1.9 Gy for ipsilateral/contralateral, p < 0.002). Nevertheless, SCS-RT did not further decrease NTCPs for xerostomia (p > 0.17). Target coverage and prevention of other side-effects were not compromised. However, increased mean oral cavity dose was observed in some patients. Lastly, in the multicenter study Dmean,SCR could be reduced by slightly adjusting the standard optimization. Contralateral Dmean,SCR reductions differed between centers (p = 0.01), which was attributed to differences in ST-RT plans. Conclusions: Stem cell sparing radiotherapy can be clinically introduced by making small adjustments to the optimization strategy and can reduce the risk of xerostomia.


  • Open Access

    Daily Head and Neck Treatment Assessment for Optimal Proton Therapy Planning Robustness

    by Leslie Chang, Sherif G. Shaaban, Emile Gogineni, Brandi Page, Harry Quon, Heng Li, Rachel Ger

    Robust optimization in proton therapy ensures adequate target coverage; however, validation of fractional plan quality and setup uncertainty in patients has not been performed. We aimed to assess plan robustness on delivered head and neck proton plans classified into two categories: (1) primary only (PO) and (2) primary and neck nodal (PNN) coverage. Registration at the machine was utilized for daily CBCT to generate a synthetic CT. The dose for the clinical target volume (CTV) and organs at risk (OAR) was compared to the expected robustness bands using 3.5% range uncertainty and 3 mm vs. 5 mm setup uncertainty. The fractional deviation was defined as D95% and V100% outside of uncertainty constraints. About 203 daily fractions from 6 patients were included for analysis. The percentage of fractions that exceeded robustness calculations was greater in 3 mm as compared to 5 mm setup uncertainty for both CTV and OAR volumes. PO plans had clinically insignificant average fractional deviation, less than 1%, in delivered D95% and V100%. In comparison, PNN plans had up to 2.2% average fractional deviation in delivered V100% using 3 mm robustness. Given the need to balance dose accuracy with OAR sparing, we recommend the utilization of 3 mm setup uncertainty as an acceptable simulation of the dose delivered.


  • Open Access

    Planning and Treatment Recommendations for Breast Proton Therapy From a Single Center's Experience

    by Rachel B. Ger, Khadija Sheikh, Emile Gogineni, Bethlehem Floreza, Victoria Croog, Heng Li, Jean L. Wright


  • Open Access

    Radiomics feature robustness as measured using an MRI phantom

    by Joonsang Lee, Angela Steinmann, Yao Ding, Hannah Lee, Constance Owens, Jihong Wang, Jinzhong Yang, David Followill, Rachel Ger, Dennis MacKin, et al.

    Radiomics involves high-throughput extraction of large numbers of quantitative features from medical images and analysis of these features to predict patients’ outcome and support clinical decision-making. However, radiomics features are sensitive to several factors, including scanning protocols. The purpose of this study was to investigate the robustness of magnetic resonance imaging (MRI) radiomics features with various MRI scanning protocol parameters and scanners using an MRI radiomics phantom. The variability of the radiomics features with different scanning parameters and repeatability measured using a test–retest scheme were evaluated using the coefficient of variation and intraclass correlation coefficient (ICC) for both T1- and T2-weighted images. For variability measures, the features were categorized into three groups: large, intermediate, and small variation. For repeatability measures, the average T1- and T2-weighted image ICCs for the phantom (0.963 and 0.959, respectively) were higher than those for a healthy volunteer (0.856 and 0.849, respectively). Our results demonstrated that various radiomics features are dependent on different scanning parameters and scanners. The radiomics features with a low coefficient of variation and high ICC for both the phantom and volunteer can be considered good candidates for MRI radiomics studies. The results of this study will assist current and future MRI radiomics studies.


  • Open Access

    Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT- and PET-imaged head and neck cancer patients

    by Rachel B. Ger, Shouhao Zhou, Baher Elgohari, Hesham Elhalawani, Dennis M. Mackin, Joseph G. Meier, Callistus M. Nguyen, Brian M. Anderson, Casey Gay, Jing Ning, et al.

    Radiomics studies require many patients in order to power them, thus patients are often combined from different institutions and using different imaging protocols. Various studies have shown that imaging protocols affect radiomics feature values. We examined whether using data from cohorts with controlled imaging protocols improved patient outcome models. We retrospectively reviewed 726 CT and 686 PET images from head and neck cancer patients, who were divided into training or independent testing cohorts. For each patient, radiomics features with different preprocessing were calculated and two clinical variables—HPV status and tumor volume—were also included. A Cox proportional hazards model was built on the training data by using bootstrapped Lasso regression to predict overall survival. The effect of controlled imaging protocols on model performance was evaluated by subsetting the original training and independent testing cohorts to include only patients whose images were obtained using the same imaging protocol and vendor. Tumor volume, HPV status, and two radiomics covariates were selected for the CT model, resulting in an AUC of 0.72. However, volume alone produced a higher AUC, whereas adding radiomics features reduced the AUC. HPV status and one radiomics feature were selected as covariates for the PET model, resulting in an AUC of 0.59, but neither covariate was significantly associated with survival. Limiting the training and independent testing to patients with the same imaging protocol reduced the AUC for CT patients to 0.55, and no covariates were selected for PET patients. Radiomics features were not consistently associated with survival in CT or PET images of head and neck patients, even within patients with the same imaging protocol.


  • Open Access

    Effects of alterations in positron emission tomography imaging parameters on radiomics features

    by Rachel B. Ger, Joseph G. Meier, Raymond B. Pahlka, Skylar Gay, Raymond Mumme, Clifton D. Fuller, Heng Li, Rebecca M. Howell, Rick R. Layman, R. Jason Stafford, et al.

    Radiomics studies require large patient cohorts, which often include patients imaged using different imaging protocols. We aimed to determine the impact of variability in imaging protocol parameters and interscanner variability using a phantom that produced feature values similar to those of patients. Positron emission tomography (PET) scans of a Hoffman brain phantom were acquired on GE Discovery 710, Siemens mCT, and Philips Vereos scanners. A standard-protocol scan was acquired on each machine, and then each parameter that could be changed was altered individually. The phantom was contoured with 10 regions of interest (ROIs). Values for 45 features with 2 different preprocessing techniques were extracted for each image. To determine the impact of each parameter on the reliability of each radiomics feature, the intraclass correlation coefficient (ICC) was calculated with the ROIs as the subjects and the parameter values as the raters. For interscanner comparisons, we compared the standard deviation of each radiomics feature value from the standard-protocol images to the standard deviation of the same radiomics feature from PET scans of 224 patients with non-small cell lung cancer. When the pixel size was resampled prior to feature extraction, all features had good reliability (ICC > 0.75) for the field of view and matrix size. The time per bed position had excellent reliability (ICC > 0.9) on all features. When the filter cutoff was restricted to values below 6 mm, all features had good reliability. Similarly, when subsets and iterations were restricted to reasonable values used in clinics, almost all features had good reliability. The average ratio of the standard deviation of features on the phantom scans to that of the NSCLC patient scans was 0.73 using fixed-bin-width preprocessing and 0.92 using 64-level preprocessing. Most radiomics feature values had at least good reliability when imaging protocol parameters were within clinically used ranges. However, interscanner variability was about equal to interpatient variability; therefore, caution must be used when combining patients scanned on equipment from different vendors in radiomics data sets.


  • Practical guidelines for handling head and neck computed tomography artifacts for quantitative image analysis

    by Rachel B. Ger, Daniel F. Craft, Dennis S. Mackin, Shouhao Zhou, Rick R. Layman, A. Kyle Jones, Hesham Elhalawani, Clifton D. Fuller, Rebecca M. Howell, Heng Li, et al.